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INTRODUCTION 
 
• Heart valve (HV) prostheses for paediatric patients have well 
documented shortcomings, predominantly related to the need for 
multiple surgeries as the child grows.  
 
• A tissue engineering approach may provide an effective 
alternative by allowing the implanted valve to grow and remodel 
with the patient.  
 
• Fibrin has been shown to be an excellent scaffold for HV tissue 
engineering studies, however, fibrin based constructs have 
shown an inability to maintain an appropriate seal upon closure, 
as a result of cell-mediated contraction of the HV leaflets [1,2].  
 
• We are currently investigating how a collagen glycosaminoglycan 
(GAG) scaffold, infiltrated with fibrin,  can provide a fully natural 
scaffold, which has sufficient stiffness to resist the contractile 
forces of cells acting upon it and thus resist this cell mediated 
contraction.  
 
• Collagen and GAGs are ideal natural materials to support fibrin 
in this application, as collagen is the major extracellular 
component of the native HV, while GAGs provide necessary 
fatigue resistance against the repeated shearing between the 
different layers of the native heart valve. 
AIMS 
• To develop and characterise a cross-linked, multicomponent 
scaffold of collagen, GAG, and fibrin (CGF) in a HV shape. 
 
• To assess vascular smooth muscle cell (VSMC) distribution, and 
response within this CGF scaffold. 
 
• To investigate the cell-mediated contraction of this CGF scaffold 
when containing VSMCs. 
RESULTS 
CONCLUSIONS 
A crosslinked, multicomponent scaffold of collagen, GAG and fibrin 
has been characterised for heart valve applications. Fibrin gels 
reinforced with a 0.75% collagen, 0.044% GAG scaffolds can resist 
VSMC induced contraction significantly more than fibrin-only gels, 
while allowing cell proliferation and maintaining excellent cell viability. 
This improvement in structural integrity may facilitate the use of fibrin 
based materials for heart valve tissue engineering. 
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Figure 7. When compared to Day 0, there was a significant increase in 
dsDNA at both Day 5 and Day 7 time points (n=3, p<0.05). This 
demonstrates the ability of cells to proliferate within the CGF scaffolds.  
Figure 6. Negligible contraction 
over 7 days was observed in the 
CGF scaffold seeded with VSMCs. 
In comparison, fibrin-only scaffolds 
with the same seeding density had 
contracted to approximately 90% of 
their original diameter after 3 days 
(n≥9).   
Figure 1. We have previously 
developed a mould for the 
construction of tri-leaflet HV 
conduits [1, 3, 4]. This mould was 
modified for producing freeze-
dried CG scaffolds. 
• A HV shaped collagen-GAG (CG) scaffold was fabricated 
through freeze drying a CG slurry in a custom built mould (see 
Figure 1). Parameters were optimised to produce a CG scaffold 
with a homogenous pore size structure.  
METHODS 
 
 
• The infiltration of fibrin throughout the CG was assessed using 
Masson’s Trichrome staining (see Figure 3).  
 
• Mechanical properties of the scaffolds were tested using a 
Zwick/Roell Z050 machine (see Figure 4). 
 
• Vascular smooth muscle cells (VSMCs) were successfully 
seeded into 5mm thick CG scaffold discs using an injection 
technique with fibrin itself as the carrier and cultured over 7 days 
(see Figure 5).  
 
• The diameters of the discs were recorded and comparisons 
drawn to the fibrin control, which was seeded at the same 
seeding density (see Figure 6).  
 
• VSMC proliferation was measured using a PicoGreen assay (see 
Figure 7) and live dead cell staining allowed cell viability to be 
assessed (see Figure 8). 
Figure 2. This image shows a sample of 
the heart valve shaped CG material, post 
cross-linking and post infiltration with 
fibrin. The material stands up under it’s 
own weight and is easy to handle.  
Figure 8. Live/dead staining of VSMCs showing live cells (green) 
and dead cells (red) at Day 3 and Day 7 time points (original 
magnification: 100X). At  Day 3, excellent viability is seen with 
some areas of unpopulated scaffold remaining. Day 7 shows 
confluent populations of viable cells, supporting the observed 
increase in proliferation as demonstrated in Figure 7.  
Figure 4. Tensile testing and compressive testing shows when 
fibrin gels are supported with a 0.75%Collagen 0.044%GAG 
matrix, their mechanical properties change significantly.  
• Once freeze dried, scaffolds were crosslinked physically by 
dehydrothermal (DHT) treatment at 105ºC for 24 hours and cross-
linked chemically using 1-Ethyl-3-(3-dimethyl aminopropyl) 
carbodiimide (EDAC) in the presence of N-hydroxysuccinimide 
(NHS) solution, which stiffens the scaffold while maintaining 
elasticity.  
 
• Different concentrations of both collagen and GAG were assessed 
to find the most stable concentration of CG to work with. 
0.75%Collagen together with 0.044%GAG was found to be the 
most stable once injected with fibrin (see Figure 2).  
 
Bottom Cuff Leaflets 
Figure 3. Masson’s Trichrome staining shows fibrin (red) has 
infiltrated through all sections of the collagen-GAG (blue) heart 
valve shaped scaffold.  
* 
* 
Figure 5. This image shows a CGF 
scaffold that was seeded with VSMCs 
at a seeding density of 3,000 cells/mm3. 
This image was taken after 7 days in 
static unrestrained culture. The gel is 
12mm in diameter. The CG dry scaffold 
was 11mm diameter prior to infiltration 
with fibrin containing VSMCs at day 0.  
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